Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC

Company Name

PENDOPHARM DIVISION OF PHARMASCIENCE INC

Totals

Shortage reports

112

Actual shortage: 13 (12%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (4%)
Resolved: 94 (84%)

Discontinuation Reports

3

To be discontinued: 0 (0%)
Discontinued: 2 (67%)
Reversed: 1 (33%)

Late reports

15 (13%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SOLYSTAT 250MG SUSPENSION Resolved 2017-04-04 2017-10-12 5422
SOLYSTAT 250MG SUSPENSION Resolved 2017-04-12 2017-10-05 6661
SOLYSTAT 250MG SUSPENSION Resolved 2017-10-23 2018-02-05 26779
SOLYSTAT 250MG SUSPENSION Resolved 2017-11-20 2018-03-13 29863
SOLYSTAT 250MG SUSPENSION Resolved 2018-02-19 2018-03-13 40154
SPASMHALT-8 325MG 400MG 8MG TABLET Actual shortage 2017-03-21 2018-12-21 3761
SPASMHALT-8 325MG 400MG 8MG TABLET Actual shortage 2018-02-01 2018-02-02 38087
XYLAC 5MG TABLET Actual shortage 2017-04-04 2018-12-22 5445
XYLAC 25MG TABLET Avoided shortage 2017-07-26 2017-10-05 17288
XYLAC 50MG TABLET Actual shortage 2017-04-04 2018-12-22 5448
XYLAC 2.5MG TABLET Resolved 2017-06-12 2017-10-05 12630
XYLAC 2.5MG TABLET Resolved 2017-08-15 2017-10-05 19370

Showing 101 to 112 of 112

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
IBAVYR 400MG TABLET Discontinued 2023-01-20 2023-01-20 182029
IBAVYR 200MG TABLET Discontinued 2023-01-20 2023-01-20 182060
OCPHYL 500MCG SOLUTION Reversed 2017-04-10 2017-04-10 6237

Showing 1 to 3 of 3